logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

John F. Seymour

Peter MacCallum Cancer Centre
H指数:111
被引数:5.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dynamic risk stratification using early CAR-T expansion in R/R LBCL treated with axicabtagene ciloleucel

基于早期axicabtagene ciloleucel扩增的R/R LBCL动态风险分层

British Journal of Haematology
IF3.8
2026-09-080
OAAI
Brydon Panozzo; Samuel Robinson; Adrian G. Minson; Jian Li; Kylie Baldwin; Hamish W. Scott; Jane Oliaro; Aaron J. N. Wong; Samantha van der Linde; Nicole L. O'Leary; Philip A. Thompson; John F. Seymour; Mary Ann Anderson; Constantine S. Tam; Simon J. Harrison; Michael J. Dickinson; David A. Westerman; Mark R. Dowling
The Landscape and Evolution of Clonal Hematopoiesis in Chronic Lymphocytic Leukemia

克隆性造血在慢性淋巴细胞白血病中的景观与演变

Blood
IF23.1
2025-12-260
OAAI
Othman Al-Sawaf; Benjamin N. Locher; Friederike Christen; Raphael Hablesreiter; Anantharamanan Rajamani; Sandra Robrecht; Can Zhang; Anna Maria Fink; Eugen Tausch; Christof Schneider; Matthias Ritgen; Karl Anton Kreuzer; Klara Kopp; Marie-Elisa Mertz; Coral Fustero-Torre; Karsten Kleo; John F. Seymour; Piers Blombery; Lars Bullinger; Brenda Chyla
Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma

维奈托克和伊布替尼诱导边缘区淋巴瘤产生持久的临床反应

Blood Advances
IF7.1
2025-12-150
OAAI
Sasanka M. Handunnetti; Amit Khot; Piers Blombery; Kate Burbury; Philip A. Thompson; David Ritchie; Rodney J. Hicks; Glenda Burke; Rachel Koldej; Mathias Bressel; Juliana Di Iulio; David A. Westerman; Stephen Lade; Andrew W. Roberts; John F. Seymour; Constantine S. Tam; Mary Ann Anderson
Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial

Epcoritamab、lenalidomide和rituximab与lenalidomide和rituximab治疗复发或难治性滤泡性淋巴瘤的比较（EPCORE FL-1）：一项全球性、开放标签、随机、III期临床试验

The Lancet
IF97.3
2025-12-070
OAAI
Lorenzo Falchi; Marcel Nijland; Huiqiang Huang; Kim M Linton; John F Seymour; Rong Tao; Michal Kwiatek; Abel Costa; Theodoros P Vassilakopoulos; Richard Greil; Ana Jiménez-Ubieto; Shane A Gangatharan; Ohad Benjamini; Catherine Thieblemont; Alessandra Tucci; Anna Elinder-Camburn; Arpad Illes; Jan Novak; Miguel A Pavlovsky; Andrew McDonald
Resistance to targeted therapies in chronic lymphocytic leukemia: Current status and perspectives for clinical and diagnostic practice

慢性淋巴细胞白血病对靶向疗法的耐药性：临床和诊断实践中的现状与展望

Leukemia
IF13.4
2025-06-240
OAAI
Piers Blombery; Thomas Chatzikonstantinou; Marina Gerousi; Richard Rosenquist; Gianluca Gaidano; Sarka Pospisilova; Andrew W. Roberts; Richard W. Birkinshaw; Davide Rossi; Lydia Scarfo; John F. Seymour; Stephan Stilgenbauer; Adrian Wiestner; Jennifer A. Woyach; Jennifer R. Brown; Paolo Ghia; Kostas Stamatopoulos
Report of Consensus Panel 4 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with non-IgM lymphoplasmacytic lymphoma

第十二届华氏巨球蛋白血症国际研讨会共识专家组4关于非IgM淋巴浆细胞样淋巴瘤患者管理的报告

Seminars in Hematology
IF4.1
2025-04-080
PRE
Alessandra Tedeschi; Rebecca Auer; Francesco Autore; Jorge J. Castillo; Moshe E. Gatt; Eva Kimby; David F. Moreno; Roger G. Owen; Lugui Qiu; Aldo M. Roccaro; Shayna Sarosiek; Naohiro Sekiguchi; John F. Seymour; Marzia Varettoni; Christopher J. Patterson; Jeffrey V. Matous; Christian Buske; Steven P. Treon; Ramon Garcia Sanz
Report of Consensus Panel 5 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with intolerance or resistance to covalent BTK inhibitors

第十二届华氏巨球蛋白血症国际研讨会第五共识小组关于对共价BTK抑制剂不耐受或耐药患者管理的报告

Seminars in Hematology
IF4.1
2025-04-080
PREAI
Jorge J. Castillo; Francesco Autore; Neil L. Berinstein; Andrew R. Branagan; Meletios A. Dimopoulos; Carlos Fernandez de Larrea; Simone Ferrero; Prashant Kapoor; Efstathios Kastritis; Jahanzaib Khwaja; Monique C. Minnema; Lugui Qiu; John F. Seymour; Josephine M.I. Vos; Christopher J. Patterson; Christian Buske; Jeffrey V. Matous; Steven P. Treon; M. Lia Palomba

研究方向

暂未获取到该数据
C
Constantine S. Tam
H 指数:76论文数:873被引数:2.9万
H
H. Miles Prince
H 指数:78论文数:730被引数:2.8万
C
Chan Y. Cheah
H 指数:48论文数:467被引数:9,283
D
David Westerman
H 指数:38论文数:233被引数:6,524
P
Piers Blombery
H 指数:39论文数:286被引数:6,159
R
Rodney J. Hicks
H 指数:97论文数:1,019被引数:4.0万
M
Mary Ann Anderson
H 指数:46论文数:361被引数:1.1万
D
David Ritchie
H 指数:55论文数:559被引数:1.2万
A
Andrew Grigg
H 指数:64论文数:439被引数:1.5万
A
Andrew W. Roberts
H 指数:87论文数:465被引数:3.4万